Molecular Instruments
Pre-clinicalHCR™ opens a new era for in situ hybridization (ISH) and immunofluorescence (IF), enabling simultaneous multiplex, quantitative, high-resolution RNA and protein imaging in the anatomical context of intact tissues, with 1-step, isothermal, enzyme-free signal amplification for all RNA and protein targets simultaneously
Founded
2015
Focus
DiagnosticsProteomics
About
HCR™ opens a new era for in situ hybridization (ISH) and immunofluorescence (IF), enabling simultaneous multiplex, quantitative, high-resolution RNA and protein imaging in the anatomical context of intact tissues, with 1-step, isothermal, enzyme-free signal amplification for all RNA and protein targets simultaneously
Funding History
2Total raised: $3.5M
Seed$3.2MUndisclosedMay 15, 2020
Grant$250KNIH SBIRJun 15, 2019
Company Info
TypePrivate
Founded2015
LocationLos Angeles, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile